Study Evaluating the Effect on Gastroduodenal Mucosa of PA32540, PA32540 and Celecoxib, and Aspirin With Celecoxib
Completed · Phase 1
Conditions studied: Healthy
In brief
We will evaluate the effect on the gastroduodenal mucosa from oral dosing of three different treatments
Key facts
- Study ID
- NCT00700687
- Run by
- POZEN
- People needed
- 90
- Starts
- 2008-06-01
- Expected to finish
- 2008-07-01
- Last updated by the study team
- 2009-01-12
Who can join
Age: 50 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy male or non-pregnant female subjects greater than or equal to 50 years as well as other standard inclusion criteria for a study of this nature
You may not qualify if…
- Standard exclusion criteria for a study of this nature
Where it is running
- Study site — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.